A detailed history of Park Place Capital Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Park Place Capital Corp holds 3,753 shares of RPRX stock, worth $101,331. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,753
Previous 3,818 1.7%
Holding current value
$101,331
Previous $100,000 6.0%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$25.63 - $29.27 $1,665 - $1,902
-65 Reduced 1.7%
3,753 $106,000
Q2 2024

Jul 02, 2024

SELL
$26.26 - $29.9 $32,825 - $37,375
-1,250 Reduced 24.66%
3,818 $100,000
Q1 2024

Apr 18, 2024

SELL
$27.46 - $31.33 $16,146 - $18,422
-588 Reduced 10.4%
5,068 $153,000
Q4 2023

Jan 24, 2024

BUY
$26.21 - $29.22 $50,821 - $56,657
1,939 Added 52.17%
5,656 $158,000
Q1 2023

May 02, 2023

SELL
$32.77 - $39.4 $2,359 - $2,836
-72 Reduced 1.9%
3,717 $133,000
Q4 2022

Feb 14, 2023

BUY
$39.17 - $44.04 $148,415 - $166,867
3,789 New
3,789 $150,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.8B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.